Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin Efficacy and Safety for Gastric Intestinal Metaplasia: a Randomized Controlled Trial

NCT05288153 is registered in ClinicalTrials.gov with Xijing Hospital of Digestive Diseases as lead sponsor.

NCT NCT05288153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05288153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin Efficacy and Safety for Gastric Intestinal Metaplasia: a Randomized Controlled Trial
Lead sponsor
Xijing Hospital of Digestive Diseases
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2022
Completion date
October 31, 2023
Enrollment
140 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastric intestinal metaplasia